Skip to content

Outset Medical is a technology company transforming the dialysis experience.

ABOUT US

Who we are
Outset Medical is changing dialysis – one of the largest, most expensive, and stagnant areas of healthcare. Headquartered in San Jose, California, Outset operates across the United States and manufactures in North America. Our team is innovative, talented, and growing quickly. Learn about careers at Outset.
What we do
We are focused on creating change, driving widespread adoption of new technology, and delivering on the promise of an improved experience for patients and lower cost of care for healthcare providers.
Why we do it
We are fueled by the opportunity to give people their lives back.

When we succeed, patients will be able to fit dialysis into their life instead of fitting their life around dialysis. They will ultimately determine when, where, and how they dialyze.

Evolution of Outset

How did we get here? A brief timeline of company milestones.

  • 2010

    HD+ is officially funded

  • 2013

    First human treatments on Tablo® in Mexico City

  • 2014

    FDA clearance for acute and chronic use, and we gain a CE Mark

  • 2015

    HD+ becomes Outset Medical

  • 2016

    2nd generation of Tablo is initiated; home clinical trial begins

  • 2017

    First use of Tablo in the acute setting at Cleveland Clinic

  • 2018

    Tablo launches commercially

  • 2019

    Home IDE completed; U.S. Dept. of HHS selects Tablo for disaster relief

  • 2020

    FDA clearance for home use; Outset goes public, listed on NASDAQ

  • 2021

    Tablo receives landmark TPNIES approval from Centers for Medicare & Medicaid Services; releases inaugural ESG report

  • Present Day

    New data shows Tablo increases patient and physician likelihood to adopt home hemodialysis

We’re honored to be recognized for our impactful and innovative solutions.

next big thing in tech winner logo
edison-awards
Kidney X Innovation Accelerator
NOMINEE medallions - Tablo Hemodialysis System (1)
GHP Leading Innovators of Dialysis Technology 2022 - North America award
A0411155_00001

Advisors

Luis Alvarez
MD
Glenn Chertow
MD MPH
Sarah Prichard
MD FRCP(C)

Board of Directors

Leslie Trigg
Chair and CEO
D. Keith Grossman
Lead Independent Director
Jim Hinrichs
Dir., Audit Committee Chair
Karen Drexler
Dir., Compensation Committee Chair
Patrick T. Hackett
Dir., Nominating & Corp. Gov. Committee Chair
Katie Szyman
Director
Andrea Saia
Director
Dale Jones
Director

Learn more about opportunities at Outset.

1321-v1 (v1.1)
Stay connected

Sign up for our monthly
“From the Outset” e-newsletter

Stay connected

Sign up for our monthly “From the Outset” e-newsletter

© Outset Medical, Inc. All rights reserved. Outset, Tablo, MyTablo, TabloHub, and Better Begins Now are trademarks of our company.